The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk.
Abstract
BACKGROUND: The risk of postnatal HIV transmission is associated with the magnitude
of the milk virus load. While HIV-specific cellular immune responses control systemic
virus load and are detectable in milk, the contribution of these responses to the
control of virus load in milk is unknown. METHODS: We assessed the magnitude of the
immunodominant GagRY11 and subdominant EnvKY9-specific CD8+ T lymphocyte response
in blood and milk of 10 A*3002+, HIV-infected Malawian women throughout the period
of lactation and correlated this response to milk virus RNA load and markers of breast
inflammation. RESULTS: The magnitude and kinetics of the HIV-specific CD8+ T lymphocyte
responses were discordant in blood and milk of the right and left breast, indicating
independent regulation of these responses in each breast. However, there was no correlation
between the magnitude of the HIV-specific CD8+ T lymphocyte response and the milk
virus RNA load. Further, there was no correlation between the magnitude of this response
and markers of breast inflammation. CONCLUSIONS: The magnitude of the HIV-specific
CD8+ T lymphocyte response in milk does not appear to be solely determined by the
milk virus RNA load and is likely only one of the factors contributing to maintenance
of low virus load in milk.
Type
Journal articleSubject
BreastCD8-Positive T-Lymphocytes
Female
HIV
Humans
Kinetics
Lactation
Malawi
Milk, Human
Mucous Membrane
RNA, Viral
T-Cell Antigen Receptor Specificity
Viral Load
Permalink
https://hdl.handle.net/10161/14732Published Version (Please cite this version)
10.1371/journal.pone.0023735Publication Info
Mahlokozera, T; Kang, HH; Goonetilleke, N; Stacey, AR; Lovingood, RV; Denny, TN; ...
Immunology, Center for HIVAIDS Vaccine (2011). The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response
and virus RNA load in breast milk. PLoS One, 6(8). pp. e23735. 10.1371/journal.pone.0023735. Retrieved from https://hdl.handle.net/10161/14732.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Thomas Norton Denny
Professor in Medicine
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine
Institute (DHVI), Associate Dean for Duke Research and Discovery @RTP, and a Professor
of Medicine in the Department of Medicine at Duke University Medical Center. He is
also an Affiliate Member of the Duke Global Health Institute. Previously, he served
on the Health Sector Advisory Council of the Duke University Fuquay School of Business.
Prior to joining Duke, he was an Associate Professor of Pathology, Labo
Sallie Robey Permar
Adjunct Professor in the Department of Pathology
Dr. Permar's work focuses on the development of vaccines to prevent vertical transmission
of neonatal viral pathogens. She has utilized the nonhuman primate model of HIV/AIDS
to characterize the virus-specific immune responses and virus evolution in breast
milk and develop a maternal vaccine regimen for protection against breast milk transmission
of HIV. In addition, Dr. Permar's lab has advanced the understanding of HIV-specific
immune responses and virus evolution in vertically-transmitting an
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info